10th August 2022 Early-stage biopharma: An opportunity for strategic investment Share EmailTwitterFacebookGoogle +PinterestTumblrLinkedinVkontakte Investments in biotech have seen consistent, long-term appreciation, even before the explosive market rallies and the IPO boom of 2019-2021. 10th August 2022
